IPP Bureau
SMS Lifesciences India receives EIR with VAI status from USFDA for API facility at Kazipally
By IPP Bureau - July 17, 2025
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
Lupin launches Loteprednol Etabonate ophthalmic suspension 0.5% in US
By IPP Bureau - July 17, 2025
Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva
Suven Life Sciences announces first patient randomized in Phase-2b clinical trial of Ropanicant
By IPP Bureau - July 17, 2025
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
Corona Remedies acquires 7 brands from Bayer's pharma division in India
By IPP Bureau - July 17, 2025
This marks the fourth acquisition by Corona Remedies from multinational corporations
Thermo Fisher Scientific to acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey
By IPP Bureau - July 17, 2025
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Cipla Health launches Astaberry's campaign 'Get the Rich Look'
By IPP Bureau - July 17, 2025
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Briefs: Godavari Biorefineries and Anuh Pharma
By IPP Bureau - July 16, 2025
Godavari Biorefineries receives patent from CNIPA
Waters, BD biosciences unit agree to $17.5 billion merger
By IPP Bureau - July 16, 2025
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
By IPP Bureau - July 15, 2025
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
FDA approves Bayer’s Finerenone for new indication in patients with HF and LVEF of ?40%
By IPP Bureau - July 15, 2025
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
India launches nutraceutical trade expo ‘Bharat Nutraverse’
By IPP Bureau - July 15, 2025
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Lilly partners with API to launch ‘Obesity Gurukul’ in India
By IPP Bureau - July 15, 2025
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
PharmaJet inks MoU with Egypt’s UPA and EVA Pharma to offer needle-free delivery for routine immunization
By IPP Bureau - July 15, 2025
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
WHO, ITU, and WIPO release new report on AI use in traditional medicine
By IPP Bureau - July 15, 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
